Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinal Degeneration | 32 | 2024 | 413 | 6.190 |
Why?
|
Retinitis Pigmentosa | 32 | 2024 | 397 | 4.880 |
Why?
|
Eye Proteins | 29 | 2023 | 632 | 3.190 |
Why?
|
Retinal Pigment Epithelium | 14 | 2023 | 303 | 2.820 |
Why?
|
Nicotinamide-Nucleotide Adenylyltransferase | 4 | 2022 | 12 | 2.530 |
Why?
|
Leber Congenital Amaurosis | 7 | 2020 | 36 | 2.230 |
Why?
|
Retina | 28 | 2024 | 2655 | 2.020 |
Why?
|
Photoreceptor Cells | 8 | 2020 | 235 | 1.600 |
Why?
|
Macular Degeneration | 8 | 2023 | 1007 | 1.510 |
Why?
|
Extracellular Matrix Proteins | 8 | 2021 | 829 | 1.340 |
Why?
|
NAD | 3 | 2023 | 614 | 1.340 |
Why?
|
Retinal Diseases | 9 | 2021 | 704 | 1.290 |
Why?
|
Eye Diseases, Hereditary | 5 | 2020 | 122 | 1.170 |
Why?
|
Complement C3a | 2 | 2018 | 66 | 1.120 |
Why?
|
Retinal Dystrophies | 5 | 2022 | 65 | 1.080 |
Why?
|
Cilia | 8 | 2020 | 492 | 1.070 |
Why?
|
Pedigree | 28 | 2024 | 4539 | 1.010 |
Why?
|
Mutation | 49 | 2022 | 30016 | 1.000 |
Why?
|
cis-trans-Isomerases | 8 | 2018 | 44 | 0.970 |
Why?
|
Cytoskeletal Proteins | 5 | 2024 | 1336 | 0.930 |
Why?
|
Ribonucleoprotein, U4-U6 Small Nuclear | 4 | 2014 | 13 | 0.910 |
Why?
|
Poly Adenosine Diphosphate Ribose | 2 | 2021 | 50 | 0.900 |
Why?
|
Retinal Cone Photoreceptor Cells | 5 | 2020 | 184 | 0.840 |
Why?
|
RNA Splicing | 7 | 2018 | 898 | 0.820 |
Why?
|
Microtubule-Associated Proteins | 12 | 2020 | 1074 | 0.800 |
Why?
|
Night Blindness | 2 | 2022 | 56 | 0.780 |
Why?
|
Photoreceptor Cells, Vertebrate | 9 | 2010 | 203 | 0.760 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2023 | 426 | 0.730 |
Why?
|
Vitamin A | 1 | 2023 | 612 | 0.700 |
Why?
|
Nucleic Acids | 1 | 2023 | 187 | 0.690 |
Why?
|
Eye Diseases | 2 | 2016 | 653 | 0.680 |
Why?
|
High-Throughput Nucleotide Sequencing | 13 | 2021 | 3634 | 0.680 |
Why?
|
Point Mutation | 3 | 2017 | 1595 | 0.670 |
Why?
|
Electroretinography | 17 | 2020 | 524 | 0.660 |
Why?
|
Genes, Dominant | 12 | 2021 | 851 | 0.660 |
Why?
|
Retinal Rod Photoreceptor Cells | 5 | 2018 | 204 | 0.640 |
Why?
|
Disease Models, Animal | 16 | 2021 | 18221 | 0.640 |
Why?
|
Usher Syndromes | 2 | 2019 | 56 | 0.610 |
Why?
|
Complement Pathway, Alternative | 1 | 2018 | 113 | 0.580 |
Why?
|
Exons | 8 | 2019 | 2381 | 0.570 |
Why?
|
Mitochondrial Diseases | 3 | 2018 | 343 | 0.560 |
Why?
|
Retinal Drusen | 2 | 2016 | 74 | 0.550 |
Why?
|
Gene Knock-In Techniques | 3 | 2013 | 420 | 0.550 |
Why?
|
Antigens, Neoplasm | 1 | 2024 | 1985 | 0.520 |
Why?
|
Calcium Channels, L-Type | 1 | 2017 | 242 | 0.520 |
Why?
|
Genetic Testing | 6 | 2024 | 3533 | 0.520 |
Why?
|
Sequence Analysis, RNA | 3 | 2017 | 2014 | 0.510 |
Why?
|
Sequence Analysis, DNA | 10 | 2024 | 4739 | 0.510 |
Why?
|
Visual Acuity | 10 | 2024 | 2672 | 0.510 |
Why?
|
Arginine | 3 | 2018 | 933 | 0.510 |
Why?
|
Rhodopsin | 6 | 2021 | 203 | 0.500 |
Why?
|
DNA, Single-Stranded | 3 | 2008 | 353 | 0.480 |
Why?
|
DNA Mutational Analysis | 12 | 2020 | 4110 | 0.480 |
Why?
|
Peroxisomal Disorders | 1 | 2014 | 12 | 0.480 |
Why?
|
Myopia | 1 | 2017 | 252 | 0.480 |
Why?
|
RNA-Binding Proteins | 4 | 2014 | 1890 | 0.480 |
Why?
|
Genetic Markers | 2 | 2020 | 2601 | 0.460 |
Why?
|
Bardet-Biedl Syndrome | 1 | 2014 | 51 | 0.450 |
Why?
|
Base Sequence | 14 | 2015 | 12421 | 0.450 |
Why?
|
Lysosomal Storage Diseases | 1 | 2014 | 79 | 0.450 |
Why?
|
Carrier Proteins | 7 | 2020 | 4935 | 0.450 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2017 | 386 | 0.440 |
Why?
|
DNA Copy Number Variations | 3 | 2024 | 2020 | 0.440 |
Why?
|
Tryptophan | 2 | 2013 | 482 | 0.440 |
Why?
|
Genetic Variation | 6 | 2024 | 6561 | 0.430 |
Why?
|
Myosins | 1 | 2014 | 404 | 0.430 |
Why?
|
Mice | 49 | 2023 | 81368 | 0.420 |
Why?
|
Translocation, Genetic | 1 | 2019 | 1392 | 0.420 |
Why?
|
Injections, Intraocular | 4 | 2024 | 33 | 0.410 |
Why?
|
Cell Cycle Proteins | 1 | 2024 | 3447 | 0.410 |
Why?
|
Corneal Dystrophies, Hereditary | 1 | 2013 | 64 | 0.410 |
Why?
|
Dependovirus | 8 | 2022 | 712 | 0.400 |
Why?
|
RNA Precursors | 3 | 2014 | 200 | 0.400 |
Why?
|
Bruch Membrane | 3 | 2018 | 65 | 0.390 |
Why?
|
Transfection | 6 | 2013 | 5766 | 0.370 |
Why?
|
Blindness | 6 | 2022 | 584 | 0.360 |
Why?
|
Cell Separation | 1 | 2016 | 1718 | 0.360 |
Why?
|
Animals | 60 | 2023 | 168201 | 0.350 |
Why?
|
Retinopathy of Prematurity | 4 | 2003 | 439 | 0.350 |
Why?
|
Extracellular Matrix | 5 | 2021 | 1718 | 0.350 |
Why?
|
Complement System Proteins | 1 | 2013 | 734 | 0.350 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1265 | 0.350 |
Why?
|
Embryonic Stem Cells | 2 | 2008 | 1262 | 0.350 |
Why?
|
Mice, Mutant Strains | 4 | 2021 | 1748 | 0.340 |
Why?
|
Phenotype | 15 | 2024 | 16571 | 0.340 |
Why?
|
Alternative Splicing | 3 | 2018 | 1088 | 0.340 |
Why?
|
Ophthalmology | 1 | 2016 | 550 | 0.340 |
Why?
|
Zebrafish | 7 | 2022 | 3007 | 0.330 |
Why?
|
Cell Culture Techniques | 2 | 2016 | 1662 | 0.320 |
Why?
|
Mice, Congenic | 1 | 2008 | 97 | 0.320 |
Why?
|
Gene Targeting | 3 | 2008 | 837 | 0.320 |
Why?
|
Genetic Diseases, Inborn | 3 | 2024 | 604 | 0.320 |
Why?
|
Optic Disk Drusen | 2 | 2023 | 38 | 0.310 |
Why?
|
Rare Diseases | 2 | 2024 | 622 | 0.310 |
Why?
|
Gene Expression Regulation | 6 | 2019 | 11874 | 0.300 |
Why?
|
Genome, Human | 2 | 2024 | 4421 | 0.300 |
Why?
|
Humans | 106 | 2024 | 760617 | 0.300 |
Why?
|
Rod Cell Outer Segment | 2 | 2007 | 51 | 0.300 |
Why?
|
Genetic Association Studies | 7 | 2020 | 2734 | 0.290 |
Why?
|
Protein Transport | 4 | 2019 | 1966 | 0.290 |
Why?
|
Retinal Neovascularization | 4 | 2005 | 288 | 0.290 |
Why?
|
Vision, Ocular | 3 | 2016 | 454 | 0.270 |
Why?
|
Genetic Vectors | 8 | 2016 | 3392 | 0.270 |
Why?
|
Gene Expression Profiling | 5 | 2020 | 9417 | 0.260 |
Why?
|
Cells, Cultured | 8 | 2020 | 18937 | 0.260 |
Why?
|
Zebrafish Proteins | 1 | 2012 | 1015 | 0.260 |
Why?
|
Microscopy, Electron, Transmission | 2 | 2018 | 695 | 0.250 |
Why?
|
Microscopy, Electron, Scanning | 2 | 2018 | 944 | 0.250 |
Why?
|
Gene Library | 4 | 2019 | 1055 | 0.240 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2004 | 30 | 0.240 |
Why?
|
Genotype | 7 | 2023 | 12978 | 0.230 |
Why?
|
Mice, Transgenic | 11 | 2014 | 9529 | 0.230 |
Why?
|
Complement C3 | 2 | 2018 | 434 | 0.220 |
Why?
|
Mice, Inbred C57BL | 16 | 2021 | 22115 | 0.220 |
Why?
|
Blotting, Western | 11 | 2011 | 5034 | 0.220 |
Why?
|
Frameshift Mutation | 3 | 2022 | 392 | 0.220 |
Why?
|
Choroideremia | 1 | 2022 | 27 | 0.200 |
Why?
|
Retinal Vessels | 3 | 2005 | 852 | 0.200 |
Why?
|
DNA, Complementary | 5 | 2022 | 1989 | 0.200 |
Why?
|
Endothelial Growth Factors | 4 | 1997 | 673 | 0.200 |
Why?
|
Stem Cells | 3 | 2004 | 3516 | 0.200 |
Why?
|
Visual Fields | 7 | 2021 | 1062 | 0.200 |
Why?
|
Visual Field Tests | 3 | 2021 | 411 | 0.200 |
Why?
|
Genetic Predisposition to Disease | 7 | 2020 | 17878 | 0.200 |
Why?
|
Mutation, Missense | 6 | 2020 | 2570 | 0.190 |
Why?
|
Mice, Knockout | 10 | 2021 | 14389 | 0.190 |
Why?
|
Chromosome Mapping | 6 | 2018 | 4611 | 0.190 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2023 | 1850 | 0.190 |
Why?
|
Alleles | 8 | 2024 | 6861 | 0.190 |
Why?
|
Lymphokines | 4 | 1997 | 925 | 0.190 |
Why?
|
STAT3 Transcription Factor | 1 | 2005 | 871 | 0.190 |
Why?
|
Complement C5 | 1 | 2021 | 103 | 0.190 |
Why?
|
Chimera | 3 | 2008 | 453 | 0.180 |
Why?
|
Optic Atrophy, Hereditary, Leber | 2 | 2013 | 50 | 0.180 |
Why?
|
Proteome | 2 | 2010 | 1857 | 0.180 |
Why?
|
Retinal Perforations | 1 | 2022 | 138 | 0.180 |
Why?
|
Vitamin E | 2 | 2023 | 872 | 0.180 |
Why?
|
Genetic Engineering | 1 | 2006 | 931 | 0.180 |
Why?
|
Family Health | 2 | 2016 | 1253 | 0.170 |
Why?
|
Complement Activation | 2 | 2021 | 445 | 0.170 |
Why?
|
Male | 47 | 2024 | 360358 | 0.170 |
Why?
|
Codon | 1 | 2021 | 600 | 0.170 |
Why?
|
RNA | 3 | 2023 | 2713 | 0.170 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2020 | 151 | 0.170 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2003 | 1692 | 0.160 |
Why?
|
Alcohol Oxidoreductases | 1 | 2020 | 168 | 0.160 |
Why?
|
Hereditary Sensory and Motor Neuropathy | 1 | 2019 | 21 | 0.160 |
Why?
|
Apoptosis Inducing Factor | 1 | 2019 | 51 | 0.160 |
Why?
|
Chronobiology Disorders | 1 | 2019 | 73 | 0.160 |
Why?
|
Molecular Sequence Data | 14 | 2011 | 17629 | 0.160 |
Why?
|
Anaphylatoxins | 1 | 2018 | 21 | 0.160 |
Why?
|
Hexokinase | 1 | 2019 | 124 | 0.160 |
Why?
|
Glycolysis | 1 | 2023 | 835 | 0.160 |
Why?
|
Mitochondrial Proton-Translocating ATPases | 1 | 2018 | 53 | 0.160 |
Why?
|
Leupeptins | 1 | 2018 | 113 | 0.150 |
Why?
|
Sirtuins | 1 | 2021 | 319 | 0.150 |
Why?
|
Embryo, Mammalian | 1 | 2004 | 1670 | 0.150 |
Why?
|
Fluorescent Antibody Technique, Indirect | 4 | 2011 | 427 | 0.150 |
Why?
|
DNA, Intergenic | 1 | 2018 | 105 | 0.150 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2018 | 188 | 0.150 |
Why?
|
Murinae | 1 | 2017 | 18 | 0.150 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2019 | 375 | 0.150 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2019 | 313 | 0.150 |
Why?
|
Polymerase Chain Reaction | 6 | 2016 | 6074 | 0.150 |
Why?
|
Cell Line | 5 | 2023 | 15576 | 0.150 |
Why?
|
Leigh Disease | 1 | 2018 | 89 | 0.140 |
Why?
|
Aging | 2 | 2016 | 8699 | 0.140 |
Why?
|
Blotting, Northern | 5 | 2011 | 1545 | 0.140 |
Why?
|
Adult | 35 | 2024 | 220969 | 0.140 |
Why?
|
Matrix Metalloproteinases | 2 | 2021 | 391 | 0.140 |
Why?
|
Ischemia | 2 | 2005 | 1884 | 0.140 |
Why?
|
Chromatography, Liquid | 1 | 2021 | 982 | 0.140 |
Why?
|
IMP Dehydrogenase | 2 | 2007 | 33 | 0.140 |
Why?
|
Female | 45 | 2024 | 392148 | 0.140 |
Why?
|
Acyltransferases | 1 | 2019 | 305 | 0.140 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2011 | 3608 | 0.140 |
Why?
|
Nystagmus, Pathologic | 1 | 2017 | 105 | 0.140 |
Why?
|
Child | 18 | 2024 | 80079 | 0.140 |
Why?
|
Organoids | 2 | 2020 | 744 | 0.140 |
Why?
|
Ribonuclease P | 1 | 2016 | 18 | 0.130 |
Why?
|
Green Fluorescent Proteins | 5 | 2008 | 2063 | 0.130 |
Why?
|
Integrases | 2 | 2011 | 518 | 0.130 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 4570 | 0.130 |
Why?
|
Adolescent | 18 | 2024 | 88234 | 0.130 |
Why?
|
3-Hydroxyacyl CoA Dehydrogenases | 1 | 2016 | 59 | 0.130 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2018 | 459 | 0.130 |
Why?
|
Genome | 2 | 2016 | 1737 | 0.130 |
Why?
|
Refractive Errors | 1 | 2017 | 147 | 0.130 |
Why?
|
Forecasting | 2 | 2015 | 2924 | 0.130 |
Why?
|
Larva | 2 | 2020 | 508 | 0.130 |
Why?
|
Cell Communication | 1 | 2023 | 1654 | 0.130 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2024 | 15908 | 0.130 |
Why?
|
Genetic Linkage | 4 | 2014 | 2340 | 0.120 |
Why?
|
Complement C5a | 1 | 2015 | 100 | 0.120 |
Why?
|
Comparative Genomic Hybridization | 1 | 2016 | 473 | 0.120 |
Why?
|
Membrane Proteins | 6 | 2024 | 7847 | 0.120 |
Why?
|
Vision Disorders | 3 | 2020 | 1088 | 0.120 |
Why?
|
Young Adult | 13 | 2024 | 59179 | 0.120 |
Why?
|
Tandem Mass Spectrometry | 1 | 2021 | 1186 | 0.120 |
Why?
|
Axoneme | 1 | 2014 | 25 | 0.120 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2018 | 2895 | 0.120 |
Why?
|
Expressed Sequence Tags | 1 | 2015 | 250 | 0.120 |
Why?
|
Occipital Lobe | 1 | 2016 | 374 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2015 | 3777 | 0.110 |
Why?
|
Fetus | 2 | 2020 | 1862 | 0.110 |
Why?
|
Computational Biology | 3 | 2015 | 3509 | 0.110 |
Why?
|
Homozygote | 5 | 2024 | 1776 | 0.110 |
Why?
|
Mitochondrial Encephalomyopathies | 1 | 2013 | 40 | 0.110 |
Why?
|
Reproducibility of Results | 5 | 2014 | 20074 | 0.110 |
Why?
|
Rats | 6 | 2014 | 23717 | 0.100 |
Why?
|
Genome, Mitochondrial | 1 | 2012 | 66 | 0.100 |
Why?
|
RNA, Transfer, Amino Acyl | 1 | 2012 | 46 | 0.100 |
Why?
|
Nerve Tissue Proteins | 2 | 2016 | 4408 | 0.100 |
Why?
|
DNA Damage | 1 | 2022 | 2446 | 0.100 |
Why?
|
Electric Impedance | 1 | 2016 | 751 | 0.100 |
Why?
|
PAX2 Transcription Factor | 1 | 2012 | 86 | 0.100 |
Why?
|
Gene Transfer Techniques | 2 | 2015 | 1202 | 0.100 |
Why?
|
Cadherins | 1 | 2016 | 901 | 0.100 |
Why?
|
Coloboma | 1 | 2012 | 59 | 0.100 |
Why?
|
Homeostasis | 1 | 2023 | 3321 | 0.100 |
Why?
|
Peptide Fragments | 1 | 2004 | 5110 | 0.100 |
Why?
|
Liposomes | 2 | 2006 | 784 | 0.100 |
Why?
|
Benzhydryl Compounds | 1 | 2018 | 915 | 0.090 |
Why?
|
DNA Primers | 3 | 2008 | 2817 | 0.090 |
Why?
|
Gene Knockdown Techniques | 2 | 2014 | 1608 | 0.090 |
Why?
|
Organ Specificity | 2 | 2013 | 1964 | 0.090 |
Why?
|
Cell Adhesion | 2 | 2018 | 3088 | 0.090 |
Why?
|
Gene Deletion | 2 | 2016 | 2661 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3800 | 0.090 |
Why?
|
Genes, Recessive | 5 | 2020 | 623 | 0.090 |
Why?
|
Tomography, Optical Coherence | 6 | 2022 | 2916 | 0.090 |
Why?
|
Molecular Sequence Annotation | 1 | 2013 | 520 | 0.090 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2018 | 1250 | 0.090 |
Why?
|
Amino Acid Sequence | 9 | 2020 | 13441 | 0.090 |
Why?
|
Ciliary Motility Disorders | 1 | 2011 | 51 | 0.090 |
Why?
|
Retinal Photoreceptor Cell Outer Segment | 1 | 2010 | 13 | 0.090 |
Why?
|
Cohort Studies | 6 | 2024 | 41457 | 0.090 |
Why?
|
Dietary Supplements | 1 | 2023 | 3411 | 0.090 |
Why?
|
Haploinsufficiency | 1 | 2012 | 336 | 0.090 |
Why?
|
Middle Aged | 19 | 2024 | 220584 | 0.090 |
Why?
|
Fluorescein Angiography | 5 | 2022 | 1059 | 0.090 |
Why?
|
Oxidative Stress | 1 | 2021 | 3113 | 0.090 |
Why?
|
Sequence Alignment | 2 | 2011 | 2178 | 0.090 |
Why?
|
RNA, Messenger | 8 | 2010 | 12758 | 0.090 |
Why?
|
Mitochondria | 3 | 2018 | 3619 | 0.090 |
Why?
|
Optic Nerve Diseases | 1 | 2013 | 342 | 0.080 |
Why?
|
Neoplasm Proteins | 2 | 2013 | 3607 | 0.080 |
Why?
|
Hyperoxia | 2 | 2005 | 258 | 0.080 |
Why?
|
Genetic Counseling | 1 | 2013 | 627 | 0.080 |
Why?
|
Erythrocytes | 1 | 2019 | 2410 | 0.080 |
Why?
|
Heterozygote | 3 | 2024 | 2780 | 0.080 |
Why?
|
Yeasts | 1 | 2010 | 278 | 0.080 |
Why?
|
Mice, Inbred A | 1 | 2008 | 245 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2011 | 1169 | 0.080 |
Why?
|
Oxygen | 2 | 1999 | 4226 | 0.080 |
Why?
|
Databases, Genetic | 2 | 2014 | 1742 | 0.080 |
Why?
|
Immunohistochemistry | 4 | 2018 | 11069 | 0.080 |
Why?
|
Fundus Oculi | 5 | 2021 | 556 | 0.080 |
Why?
|
Targeted Gene Repair | 1 | 2008 | 20 | 0.080 |
Why?
|
COS Cells | 2 | 2014 | 1130 | 0.080 |
Why?
|
Child, Preschool | 8 | 2024 | 42188 | 0.080 |
Why?
|
Sequence Deletion | 1 | 2012 | 1490 | 0.070 |
Why?
|
Diabetic Retinopathy | 2 | 2016 | 1273 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2872 | 0.070 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2012 | 437 | 0.070 |
Why?
|
Mice, Inbred DBA | 1 | 2008 | 619 | 0.070 |
Why?
|
ADAM Proteins | 1 | 2009 | 238 | 0.070 |
Why?
|
Crosses, Genetic | 1 | 2008 | 750 | 0.070 |
Why?
|
Mitochondrial Proteins | 1 | 2013 | 974 | 0.070 |
Why?
|
Developmental Disabilities | 1 | 2016 | 1509 | 0.070 |
Why?
|
DNA | 3 | 2016 | 7196 | 0.070 |
Why?
|
Microscopy, Fluorescence | 3 | 2008 | 2639 | 0.070 |
Why?
|
Neomycin | 1 | 2006 | 92 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2010 | 2747 | 0.070 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2006 | 55 | 0.070 |
Why?
|
Animals, Newborn | 2 | 2005 | 2668 | 0.070 |
Why?
|
Microscopy, Confocal | 4 | 2008 | 1970 | 0.070 |
Why?
|
Autoantigens | 1 | 2010 | 888 | 0.070 |
Why?
|
Renal Insufficiency | 1 | 2012 | 808 | 0.060 |
Why?
|
CHO Cells | 3 | 2004 | 1387 | 0.060 |
Why?
|
Software | 3 | 2021 | 4431 | 0.060 |
Why?
|
Cataract | 1 | 2012 | 831 | 0.060 |
Why?
|
Cattle | 5 | 2007 | 3841 | 0.060 |
Why?
|
Models, Genetic | 3 | 2011 | 3431 | 0.060 |
Why?
|
Haplotypes | 2 | 2024 | 2713 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 3 | 2004 | 3730 | 0.060 |
Why?
|
Cell Nucleus | 2 | 2012 | 2894 | 0.060 |
Why?
|
Infant | 5 | 2019 | 36152 | 0.060 |
Why?
|
Proteins | 2 | 2018 | 6030 | 0.060 |
Why?
|
Apoptosis | 1 | 2021 | 9476 | 0.060 |
Why?
|
Cricetinae | 3 | 2004 | 2424 | 0.060 |
Why?
|
Drug Resistance, Microbial | 1 | 2008 | 825 | 0.060 |
Why?
|
Benchmarking | 1 | 2011 | 1045 | 0.060 |
Why?
|
Arrestin | 1 | 2004 | 30 | 0.060 |
Why?
|
Nuclear Localization Signals | 1 | 2004 | 77 | 0.060 |
Why?
|
Cluster Analysis | 1 | 2011 | 2700 | 0.060 |
Why?
|
Family | 2 | 2012 | 3193 | 0.060 |
Why?
|
Mammals | 2 | 2007 | 1131 | 0.060 |
Why?
|
Sendai virus | 1 | 2023 | 22 | 0.060 |
Why?
|
Oxidative Phosphorylation | 2 | 2018 | 495 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2016 | 14648 | 0.060 |
Why?
|
HEK293 Cells | 3 | 2019 | 4269 | 0.060 |
Why?
|
Glaucoma | 1 | 2013 | 1185 | 0.060 |
Why?
|
RNA Interference | 1 | 2012 | 2830 | 0.060 |
Why?
|
Gene Expression | 4 | 2008 | 7568 | 0.050 |
Why?
|
Protein Sorting Signals | 1 | 2004 | 278 | 0.050 |
Why?
|
Dark Adaptation | 4 | 2009 | 222 | 0.050 |
Why?
|
Laser Coagulation | 2 | 1997 | 330 | 0.050 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2022 | 27 | 0.050 |
Why?
|
Genes, X-Linked | 2 | 2016 | 128 | 0.050 |
Why?
|
Electroporation | 1 | 2004 | 233 | 0.050 |
Why?
|
Complement Factor B | 1 | 2023 | 57 | 0.050 |
Why?
|
Base Pair Mismatch | 1 | 2003 | 92 | 0.050 |
Why?
|
Luminescent Proteins | 2 | 2003 | 836 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 4 | 1997 | 748 | 0.050 |
Why?
|
Retinal Dysplasia | 1 | 2002 | 12 | 0.050 |
Why?
|
Gene Silencing | 2 | 2006 | 1503 | 0.050 |
Why?
|
Quality of Life | 1 | 2024 | 13347 | 0.050 |
Why?
|
Basement Membrane | 1 | 2003 | 349 | 0.050 |
Why?
|
INDEL Mutation | 1 | 2022 | 265 | 0.050 |
Why?
|
beta-Galactosidase | 1 | 2003 | 574 | 0.050 |
Why?
|
Ribonucleoproteins | 1 | 2004 | 360 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2020 | 22148 | 0.050 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2003 | 453 | 0.050 |
Why?
|
Cytochrome b Group | 2 | 1991 | 59 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2013 | 9586 | 0.050 |
Why?
|
Subcellular Fractions | 2 | 2013 | 531 | 0.050 |
Why?
|
Infant, Newborn | 6 | 2018 | 26180 | 0.050 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2003 | 278 | 0.050 |
Why?
|
Reflex, Pupillary | 2 | 2013 | 62 | 0.050 |
Why?
|
Drug Resistance | 1 | 2006 | 1594 | 0.040 |
Why?
|
Cell Differentiation | 4 | 2023 | 11514 | 0.040 |
Why?
|
Granulomatous Disease, Chronic | 2 | 1991 | 173 | 0.040 |
Why?
|
Flow Cytometry | 2 | 2018 | 5863 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2001 | 294 | 0.040 |
Why?
|
Models, Animal | 1 | 2006 | 2109 | 0.040 |
Why?
|
In Situ Hybridization | 3 | 2003 | 1900 | 0.040 |
Why?
|
Pancreatitis, Acute Necrotizing | 1 | 2001 | 173 | 0.040 |
Why?
|
Proteomics | 1 | 2013 | 3836 | 0.040 |
Why?
|
Cytoplasm | 1 | 2004 | 1503 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2010 | 2090 | 0.040 |
Why?
|
Molecular Weight | 1 | 2002 | 2185 | 0.040 |
Why?
|
Luminescence | 1 | 2019 | 108 | 0.040 |
Why?
|
Epoprostenol | 1 | 2000 | 247 | 0.040 |
Why?
|
Automation | 1 | 2021 | 585 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7995 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2003 | 1525 | 0.040 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2001 | 410 | 0.040 |
Why?
|
Cats | 1 | 2020 | 975 | 0.040 |
Why?
|
Microtubules | 1 | 2004 | 1073 | 0.040 |
Why?
|
Crystallins | 1 | 1998 | 75 | 0.040 |
Why?
|
Founder Effect | 1 | 2018 | 185 | 0.040 |
Why?
|
Recombination, Genetic | 1 | 2003 | 1519 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2022 | 569 | 0.040 |
Why?
|
Age of Onset | 2 | 2016 | 3302 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2010 | 4512 | 0.040 |
Why?
|
GTP-Binding Proteins | 1 | 2022 | 949 | 0.040 |
Why?
|
RNA Splice Sites | 1 | 2018 | 210 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2004 | 3792 | 0.040 |
Why?
|
Jews | 2 | 2018 | 356 | 0.040 |
Why?
|
Mesenchymal Stem Cells | 1 | 2008 | 1642 | 0.040 |
Why?
|
DNA Repair | 1 | 2006 | 2043 | 0.040 |
Why?
|
Gene Amplification | 1 | 2002 | 1087 | 0.040 |
Why?
|
Chromosome Aberrations | 1 | 2023 | 1768 | 0.040 |
Why?
|
Rod Opsins | 1 | 2017 | 108 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1650 | 0.030 |
Why?
|
DNA, Mitochondrial | 2 | 2012 | 865 | 0.030 |
Why?
|
Dimerization | 1 | 2018 | 890 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1835 | 0.030 |
Why?
|
Atrophy | 1 | 2022 | 1631 | 0.030 |
Why?
|
Fibroblasts | 2 | 2019 | 4137 | 0.030 |
Why?
|
Canada | 1 | 2022 | 2118 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 7389 | 0.030 |
Why?
|
Virulence | 1 | 2020 | 1299 | 0.030 |
Why?
|
Cell Death | 1 | 2001 | 1677 | 0.030 |
Why?
|
Injections | 2 | 2009 | 832 | 0.030 |
Why?
|
Saudi Arabia | 1 | 2016 | 210 | 0.030 |
Why?
|
Circadian Rhythm | 2 | 2019 | 2569 | 0.030 |
Why?
|
Syndrome | 2 | 2013 | 3268 | 0.030 |
Why?
|
Rabbits | 1 | 2002 | 4770 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2020 | 1739 | 0.030 |
Why?
|
Prospective Studies | 2 | 2022 | 54360 | 0.030 |
Why?
|
Receptors, Growth Factor | 1 | 1995 | 326 | 0.030 |
Why?
|
Retreatment | 1 | 2016 | 596 | 0.030 |
Why?
|
Nerve Regeneration | 1 | 2020 | 796 | 0.030 |
Why?
|
Eye | 1 | 1998 | 712 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2017 | 813 | 0.030 |
Why?
|
RNA, Transfer | 1 | 2016 | 289 | 0.030 |
Why?
|
Risk Assessment | 2 | 2013 | 23972 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 1997 | 3492 | 0.030 |
Why?
|
Oligonucleotides, Antisense | 1 | 1996 | 458 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2015 | 64568 | 0.030 |
Why?
|
Neurogenesis | 1 | 2020 | 862 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2003 | 1810 | 0.030 |
Why?
|
Lipids | 1 | 2004 | 3332 | 0.030 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 1994 | 186 | 0.030 |
Why?
|
Internationality | 1 | 2018 | 1000 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2003 | 2048 | 0.030 |
Why?
|
Trans-Activators | 1 | 2002 | 2852 | 0.030 |
Why?
|
Polymorphism, Single-Stranded Conformational | 2 | 2003 | 329 | 0.030 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2013 | 367 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2018 | 1988 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2016 | 12142 | 0.020 |
Why?
|
F-Box Proteins | 1 | 2013 | 201 | 0.020 |
Why?
|
DNA Probes | 1 | 2012 | 541 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2008 | 8998 | 0.020 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 1991 | 94 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2013 | 489 | 0.020 |
Why?
|
Gene Frequency | 1 | 2018 | 3601 | 0.020 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2012 | 239 | 0.020 |
Why?
|
Algorithms | 1 | 2011 | 14018 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2002 | 8166 | 0.020 |
Why?
|
Transducin | 1 | 2010 | 42 | 0.020 |
Why?
|
Genetic Loci | 1 | 2020 | 2624 | 0.020 |
Why?
|
Nystagmus, Physiologic | 1 | 2009 | 29 | 0.020 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2010 | 102 | 0.020 |
Why?
|
Phylogeny | 1 | 2017 | 2806 | 0.020 |
Why?
|
Physical Chromosome Mapping | 1 | 2010 | 183 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 1 | 2010 | 460 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2016 | 39063 | 0.020 |
Why?
|
Aged | 7 | 2018 | 169042 | 0.020 |
Why?
|
Down-Regulation | 1 | 1996 | 2915 | 0.020 |
Why?
|
Centrosome | 1 | 2010 | 209 | 0.020 |
Why?
|
Synaptic Vesicles | 1 | 2010 | 190 | 0.020 |
Why?
|
Cryosurgery | 1 | 1994 | 468 | 0.020 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2010 | 304 | 0.020 |
Why?
|
Phagocytosis | 1 | 2014 | 1526 | 0.020 |
Why?
|
rab GTP-Binding Proteins | 1 | 2010 | 250 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2022 | 80566 | 0.020 |
Why?
|
Neutrophils | 2 | 1991 | 3763 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3575 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2011 | 5780 | 0.020 |
Why?
|
Consanguinity | 2 | 2009 | 456 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 1995 | 1626 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5789 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2010 | 1463 | 0.020 |
Why?
|
Transgenes | 1 | 2009 | 1008 | 0.020 |
Why?
|
Ion Channels | 1 | 2011 | 1039 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5866 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4473 | 0.020 |
Why?
|
Safety | 1 | 2009 | 1149 | 0.020 |
Why?
|
Sheep | 1 | 2007 | 1436 | 0.010 |
Why?
|
Cloning, Molecular | 3 | 1998 | 4172 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3680 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2013 | 1894 | 0.010 |
Why?
|
Cell Compartmentation | 1 | 2004 | 384 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2006 | 1703 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5822 | 0.010 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2003 | 206 | 0.010 |
Why?
|
Models, Biological | 1 | 2019 | 9461 | 0.010 |
Why?
|
Isoenzymes | 1 | 2007 | 1687 | 0.010 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2008 | 499 | 0.010 |
Why?
|
Risk Factors | 2 | 2016 | 74115 | 0.010 |
Why?
|
Disease Progression | 2 | 2009 | 13495 | 0.010 |
Why?
|
Dogs | 1 | 2007 | 3838 | 0.010 |
Why?
|
Cricetulus | 1 | 2004 | 814 | 0.010 |
Why?
|
Xenopus | 1 | 2004 | 711 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10754 | 0.010 |
Why?
|
Time Factors | 3 | 2011 | 39913 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2006 | 1697 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2010 | 6188 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3419 | 0.010 |
Why?
|
Brain Diseases | 1 | 2010 | 1545 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12661 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2018 | 58894 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2004 | 1557 | 0.010 |
Why?
|
Endoscopy, Digestive System | 1 | 2001 | 352 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2002 | 2561 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2013 | 4947 | 0.010 |
Why?
|
Light | 1 | 2004 | 1352 | 0.010 |
Why?
|
Tomography | 1 | 2000 | 411 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1998 | 777 | 0.010 |
Why?
|
Triplets | 1 | 1997 | 42 | 0.010 |
Why?
|
Swine | 1 | 2007 | 5907 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 26049 | 0.010 |
Why?
|
Pancreatectomy | 1 | 2001 | 811 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15689 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6520 | 0.010 |
Why?
|
3T3 Cells | 1 | 1998 | 1085 | 0.010 |
Why?
|
Polymorphism, Genetic | 2 | 2001 | 4242 | 0.010 |
Why?
|
Lens, Crystalline | 1 | 1998 | 387 | 0.010 |
Why?
|
Drainage | 1 | 2001 | 1156 | 0.010 |
Why?
|
Solubility | 1 | 1995 | 1089 | 0.010 |
Why?
|
Endothelium | 1 | 1995 | 764 | 0.010 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1995 | 647 | 0.010 |
Why?
|
Age Factors | 1 | 2009 | 18381 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2000 | 1963 | 0.010 |
Why?
|
Signal Transduction | 1 | 2016 | 23416 | 0.010 |
Why?
|
Nucleic Acid Conformation | 1 | 1996 | 901 | 0.010 |
Why?
|
Fatal Outcome | 1 | 1997 | 1835 | 0.010 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 1995 | 664 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2001 | 6305 | 0.010 |
Why?
|
Retinal Ganglion Cells | 1 | 1997 | 810 | 0.010 |
Why?
|
Hybrid Cells | 1 | 1990 | 422 | 0.010 |
Why?
|
Sex Chromosomes | 1 | 1971 | 101 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1991 | 817 | 0.010 |
Why?
|
Cornea | 1 | 1998 | 1332 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2000 | 2644 | 0.010 |
Why?
|
Hemodynamics | 1 | 2000 | 4160 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 29600 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 1991 | 1433 | 0.010 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 1990 | 343 | 0.010 |
Why?
|
Cytosol | 1 | 1991 | 886 | 0.000 |
Why?
|
Tumor Cells, Cultured | 1 | 1996 | 6126 | 0.000 |
Why?
|
Endothelium, Vascular | 1 | 2000 | 4433 | 0.000 |
Why?
|
Introns | 1 | 1990 | 968 | 0.000 |
Why?
|
Survival Rate | 1 | 2001 | 12719 | 0.000 |
Why?
|
Recurrence | 1 | 1997 | 8426 | 0.000 |
Why?
|
Kinetics | 1 | 1991 | 6370 | 0.000 |
Why?
|
Immunoglobulin G | 1 | 1995 | 4533 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2001 | 15828 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 2001 | 7402 | 0.000 |
Why?
|
Cell Membrane | 1 | 1991 | 3680 | 0.000 |
Why?
|
Pregnancy | 1 | 1997 | 29868 | 0.000 |
Why?
|
England | 1 | 1971 | 526 | 0.000 |
Why?
|
Pennsylvania | 1 | 1971 | 612 | 0.000 |
Why?
|
Italy | 1 | 1971 | 842 | 0.000 |
Why?
|